2GM1 | pdb_00002gm1

Crystal structure of the mitotic kinesin eg5 in complex with mg-adp and n-(3-aminopropyl)-n-((3-benzyl-5-chloro-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)(cyclopropyl)methyl)-4-methylbenzamide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.269 (Depositor), 0.235 (DCC) 
  • R-Value Work: 
    0.230 (Depositor), 0.228 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 2GM1

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors.

Kim, K.S.Lu, S.Cornelius, L.A.Lombardo, L.J.Borzilleri, R.M.Schroeder, G.M.Sheng, C.Rovnyak, G.Crews, D.Schmidt, R.J.Williams, D.K.Bhide, R.S.Traeger, S.C.McDonnell, P.A.Mueller, L.Sheriff, S.Newitt, J.A.Pudzianowski, A.T.Yang, Z.Wild, R.Lee, F.Y.Batorsky, R.Ryder, J.S.Ortega-Nanos, M.Shen, H.Gottardis, M.Roussell, D.L.

(2006) Bioorg Med Chem Lett 16: 3937-3942

  • DOI: https://doi.org/10.1016/j.bmcl.2006.05.037
  • Primary Citation Related Structures: 
    2GM1

  • PubMed Abstract: 

    Synthesis and SAR of substituted pyrrolotriazine-4-one analogues as Eg5 inhibitors are described. Many of these analogues displayed potent inhibitory activities in the Eg5 ATPase and A2780 cell proliferation assays. In addition, pyrrolotriazine-4-one analogue 26 demonstrated in vivo efficacy in an iv P388 murine leukemia model. Both NMR and X-ray crystallographic studies revealed that these analogues bind to an allosteric site on the Eg5 protein.


  • Organizational Affiliation
    • Department of Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA. kyoung.kim@bms.com

Macromolecule Content 

  • Total Structure Weight: 168.14 kDa 
  • Atom Count: 10,443 
  • Modeled Residue Count: 1,297 
  • Deposited Residue Count: 1,472 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
KINESIN-RELATED MOTOR PROTEIN EG5A,
B,
C [auth D],
D [auth E]
368Homo sapiensMutation(s): 0 
Gene Names: EG5
UniProt & NIH Common Fund Data Resources
Find proteins for P52732 (Homo sapiens)
Explore P52732 
Go to UniProtKB:  P52732
PHAROS:  P52732
GTEx:  ENSG00000138160 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP52732
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
2AZ

Query on 2AZ



Download:Ideal Coordinates CCD File
G [auth A],
K [auth B],
O [auth D],
S [auth E]
N-(3-AMINOPROPYL)-N-[(R)-(3-BENZYL-5-CHLORO-4-OXO-3,4-DIHYDROPYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)(CYCLOPROPYL)METHYL]-4-METHYLBENZAMIDE
C28 H30 Cl N5 O2
IKORZPHBTIOSSU-XMMPIXPASA-N
ADP

Query on ADP



Download:Ideal Coordinates CCD File
H [auth A],
L [auth B],
P [auth D],
T [auth E]
ADENOSINE-5'-DIPHOSPHATE
C10 H15 N5 O10 P2
XTWYTFMLZFPYCI-KQYNXXCUSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
I [auth B]
J [auth B]
M [auth D]
E [auth A],
F [auth A],
I [auth B],
J [auth B],
M [auth D],
N [auth D],
Q [auth E],
R [auth E]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.269 (Depositor), 0.235 (DCC) 
  • R-Value Work:  0.230 (Depositor), 0.228 (DCC) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 64.7α = 90
b = 112.6β = 90.2
c = 108.1γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
AMoREphasing
CNSrefinement
PDB_EXTRACTdata extraction
CNXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2006-06-27 
  • Deposition Author(s): Sheriff, S.

Revision History  (Full details and data files)

  • Version 1.0: 2006-06-27
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2017-10-18
    Changes: Refinement description
  • Version 1.4: 2024-02-14
    Changes: Data collection, Database references, Derived calculations
  • Version 1.5: 2024-04-03
    Changes: Refinement description